Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Register Today for April 26 ASCO/FDA/Friends Tissue Agnostic Workshop

Oncology Practice Insider

The Workshop on Development of Tissue-Agnostic, Biomarker-Based Indications, cohosted by ASCO, FDA, and Friends of Cancer Research, is now open for registration. The April 26 full-day event aims to bring together members of various sectors to identify clinical trial designs and strategies that can accelerate drug development based on biomarkers that are agnostic to tumor types. Learn more and register.